Ivor Elrifi, CEO of Tiziana Life Sciences, commented, “Partnering with Renaissance is a significant milestone in our mission to bring intranasal foralumab to patients in need. Their proven track ...
If you’ve ever wondered how Thon’s year-round fundraising efforts manage to raise that money, and where the money goes ...
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...
The restoration of glycemic control through islet transplantation currently remains as one of the only approaches to achieve insulin independence for type-I ...
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its ...
Fabry disease is an X-linked lysosomal storage disorder caused by a deficiency of the enzyme α-galactosidase A (GLA), which leads to complex multisystemic involvement, with the majority of patients ...
BURNABY, British Columbia, Feb. 10, 2025 (GLOBE NEWSWIRE) — Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunomodulation ...
In this manner, it may be possible to uncover unique signals that drive EC phenotypes that are associated within immunomodulation and long-term graft survival. Future research studies may also ...
Mechanism of ivermectin induced inhibition of importin α/β mediated coronavirus proteins transport. cNLS : classical Nuclear Localization Signal. *Image courtesy: CDC/Alissa Eckert, MS; Dan Higgins, ...
1Jiangxi Key Laboratory of Oncology, JXHC Key Laboratory of Tumor Metastasis, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Cancer Institute, Nanchang, ...
Sustained Immunomodulation: SAB-142 demonstrated a clinically validated multi-target MOA with sustained immunomodulation. MoA Analogous to Rabbit ATG: The mechanism of action (MoA) of SAB-142 ...